US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sionna Therapeutics

17.22

+1.197.42%

Volume:167.98K

Turnover:2.82M

Market Cap:759.27M

PE:-2.53

High:17.40

Open:16.16

Low:16.12

Close:16.03

Loading ...

Overview Company News Filings

TD Cowen Initiates Sionna Therapeutics at Buy

MT Newswires Live

Sionna Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating

THOMSON REUTERS

Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation

Sionna Therapeutics initiated with a Buy at Guggenheim

Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market

Sionna Therapeutics: Innovative NBD1 Stabilizers and Strategic Synergies Drive Buy Rating

Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently

BRIEF-Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10

Atlas Venture Fund Xi L.p Reports 6.5% Stake in Sionna Therapeutics as of Feb 10 - SEC Filing

THOMSON REUTERS

Andreas Halvorsen's Strategic Acquisition in Sionna Therapeutics Inc

Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year?

BRIEF-Orbimed Advisors Llc Reports 8.4% Stake In Sionna Therapeutics As Of Feb 10 - SEC Filing

Orbimed Advisors Llc Reports 8.4% Stake in Sionna Therapeutics as of Feb 10 - SEC Filing

THOMSON REUTERS

Major Stock Acquisition Signals Confidence in Sionna Therapeutics

Major Stakeholders Make Bold Moves on Sionna Therapeutics Stock!

Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Opening Day: Sionna Therapeutics, Titan America make public debut

BUZZ-Sionna Therapeutics jumps nearly 40% in cracking Nasdaq debut

Stock Track | Sionna Therapeutics Soars 38.89% on IPO Debut, Fueled by Strong Investor Demand

BUZZ-Sionna Therapeutics set to open 33% above offer price after upsized $191 mln IPO

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SION/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SION","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":17.22,"timestamp":1749240000000,"preClose":16.03,"halted":0,"volume":167979,"delay":0,"floatShares":13432778,"shares":44092117,"eps":-6.81129,"marketStatus":"Pre-Mkt","change":1.19,"latestTime":"06-09 08:55:17 EDT","open":16.16,"high":17.4,"low":16.12,"amount":2822453.373222,"amplitude":0.07985,"askPrice":27.55,"askSize":200,"bidPrice":13.42,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-6.81129,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749475800000},"marketStatusCode":1,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":17.22,"postHourTrading":{"tag":"盘后","latestPrice":16.8,"preClose":17.22,"latestTime":"18:01 EDT","volume":12655,"amount":213977.24,"timestamp":1749247270478},"volumeRatio":1.1218389240864564},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","floatShares":13432778,"roa":"-37.10%","roe":"-61.44%","lyrEps":-15.986072,"volumeRatio":1.1218389240864564,"shares":44092117,"dividePrice":0,"high":17.4,"amplitude":0.07985,"preClose":16.03,"low":16.12,"week52Low":7.255,"pbRate":"2.16","week52High":25.19,"institutionHeld":0,"latestPrice":17.22,"committee":-0.99005,"eps":-6.81129,"divideRate":0,"volume":167979,"delay":0,"ttmEps":-6.81129,"open":16.16,"prevYearClose":18,"prevWeekClose":17.22,"prevMonthClose":13.69,"prevQuarterClose":10.46,"fiveDayClose":13.69,"twentyDayClose":12.57,"sixtyDayClose":17.11},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SION\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516735526","title":"TD Cowen Initiates Sionna Therapeutics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2516735526","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516735526?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:30","pubTimestamp":1741091429,"startTime":"0","endTime":"0","summary":"TD Cowen Initiates Sionna Therapeutics at Buy","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4207","SION","BK4566","COWN","TD","BK4585","BK4127","BK4139"],"gpt_icon":0},{"id":"2516678739","title":"Sionna Therapeutics Inc : TD Cowen Initiates Coverage With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516678739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516678739?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:28","pubTimestamp":1741091325,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2516678805","title":"Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2516678805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516678805?lang=en_us&edition=fundamental","pubTime":"2025-03-04 19:55","pubTimestamp":1741089335,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Sionna Therapeutics (SION) with an Early-Stage Biotech designation. Lead assets SION-719 and SION-451 are desig...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/goldman-sachs-starts-sionna-therapeutics-with-early-stage-biotech-designation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/goldman-sachs-starts-sionna-therapeutics-with-early-stage-biotech-designation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002270589.USD","LU0106831901.USD","SSI","IE0004086264.USD","BK4516","SION","BK4552","IE00BSNM7G36.USD","BK4127","LU2237438978.USD","LU2471134796.USD","LU1868836591.USD","LU2237443895.HKD","BK4139","LU2750360997.AUD","BK4533","BK4504","IE0034235188.USD","IE00BFXG1179.USD","LU1868836757.USD","LU2237443382.USD","LU2471134879.HKD","IE0004091025.USD","LU2237443978.SGD","BK4585","LU2237443465.HKD","LU2750360641.GBP","LU2471134952.CNY","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU1868837136.USD","BK4550","LU1868836914.USD","LU1868837300.USD","LU0096364046.USD","LU2237443549.SGD","LU2471134523.USD","LU0061475181.USD","BK4588","LU1668664300.SGD","LU2237443622.USD","LU1791807156.HKD"],"gpt_icon":0},{"id":"2516264946","title":"Sionna Therapeutics initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2516264946","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516264946?lang=en_us&edition=fundamental","pubTime":"2025-03-04 17:55","pubTimestamp":1741082142,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of Sionna Therapeutics (SION) with a Buy rating and $45 price target The firm has a positive view of NBD1 stabilizati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-initiated-with-a-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sionna-therapeutics-initiated-with-a-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2516623001","title":"Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2516623001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516623001?lang=en_us&edition=fundamental","pubTime":"2025-03-04 17:26","pubTimestamp":1741080389,"startTime":"0","endTime":"0","summary":"Paul Matteis, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Sionna Therapeutics, Inc. (SION). Paul Matteis has given his Buy r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-promising-nbd1-stabilizers-poised-to-challenge-vertex-in-the-11-billion-cf-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-promising-nbd1-stabilizers-poised-to-challenge-vertex-in-the-11-billion-cf-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","VTNR","LU0058720904.USD","LU0823416689.USD","SION","IE00B19Z3581.USD","LU2417539215.USD","IE00B19Z9Z06.USD","LU0256863811.USD","LU2362541513.USD","IE00BZ9MQY76.HKD","IE0002141913.USD","VERX","LU0757428866.USD","BK4533","BK4139","BK4138","IE00B19Z3B42.SGD","LU0061475181.USD","CF","LU1815336091.USD","IE00B4R5TH58.HKD","BK4567","BK4532","LU2362541273.HKD","LU1093756168.USD","LU2362540622.SGD","LU1093756325.SGD","BK4093","IE0009355771.USD","LU1559883803.SGD","LU1069344957.HKD","LU0417517546.SGD","LU0566484027.USD","LU0234570918.USD","BK4588","LU0889565916.HKD","VRTX","LU2456880835.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU2324357040.USD","IE0002270589.USD","LU1035775433.USD","IE00BFTCPJ56.SGD","LU0079474960.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU2237438978.USD","LU1585245621.USD"],"gpt_icon":0},{"id":"2516462587","title":"Sionna Therapeutics: Innovative NBD1 Stabilizers and Strategic Synergies Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516462587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516462587?lang=en_us&edition=fundamental","pubTime":"2025-03-04 17:26","pubTimestamp":1741080371,"startTime":"0","endTime":"0","summary":"Yatin Suneja, an analyst from Guggenheim, has initiated a new Buy rating on Sionna Therapeutics, Inc. (SION). Yatin Suneja has given his Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-innovative-nbd1-stabilizers-and-strategic-synergies-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sionna-therapeutics-innovative-nbd1-stabilizers-and-strategic-synergies-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"gpt_icon":0},{"id":"2516651996","title":"Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2516651996","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516651996?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:57","pubTimestamp":1741024667,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are going to take a look at where Sionna Therapeutics, Inc.  stands against other stocks with at least $10 million in insider spending recently.Since Donald Trump took office, the stock market has experienced a roller coaster ride. Nonetheless, despite concerns about tariffs, job cuts, policy changes, and geopolitical uncertainties, the broader market has risen by 1.46% year-to-date. Furthermore, equity strategists in a Reuters poll project that the broader market will finish the year 9% higher than its current level.“Many analysts agree with this projection, arguing that the Trump administration’s policies won’t have long-term negative impacts on economic growth or inflation. Furthermore, Trump is often considered the most pro-stock market president in American history.Our research has shown that we can outperform the market by imitating the top stock picks of the best","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sionna-therapeutics-inc-sion-among-175747124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USAW.SI","MNQmain","QLD","CF",".IXIC","TSYW.SI","BK4588","PSQ","USJW.SI","TQQQ","SION","BK4585","SQQQ","BK4139","NVIW.SI","NQmain","QID","BK4093"],"gpt_icon":1},{"id":"2512116891","title":"BRIEF-Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10","url":"https://stock-news.laohu8.com/highlight/detail?id=2512116891","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512116891?lang=en_us&edition=fundamental","pubTime":"2025-02-19 07:03","pubTimestamp":1739919816,"startTime":"0","endTime":"0","summary":"BRIEF-Atlas Venture Fund Xi L.P Reports 6.5% Stake In Sionna Therapeutics As Of Feb 10 Feb 18  - Sionna Therapeutics Inc SION.O:ATLAS VENTURE FUND XI L.P REPORTS 6.5% STAKE IN SIONNA THERAPEUTICS AS OF FEB 10 - SEC FILINGSource text: [ID:]Further company coverage: SION.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P915N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2512113493","title":"Atlas Venture Fund Xi L.p Reports 6.5% Stake in Sionna Therapeutics as of Feb 10 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2512113493","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512113493?lang=en_us&edition=fundamental","pubTime":"2025-02-19 06:33","pubTimestamp":1739918009,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P915N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION","BK4139"],"gpt_icon":0},{"id":"2512162940","title":"Andreas Halvorsen's Strategic Acquisition in Sionna Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162940","media":"GuruFocus","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512162940?lang=en_us&edition=fundamental","pubTime":"2025-02-18 21:29","pubTimestamp":1739885357,"startTime":"0","endTime":"0","summary":"On February 10, 2025, Andreas Halvorsen (Trades, Portfolio), a prominent figure in the investment world, made a significant move by acquiring 2,952,754 shares of Sionna Therapeutics Inc (SION, Financi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2701996/andreas-halvorsens-strategic-acquisition-in-sionna-therapeutics-inc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["LU0106831901.USD","LU1720051108.HKD","BK4568","BK4516","BK4551","BNTX","LU1548497426.USD","LU1732800096.USD","LU1989772840.SGD","LU2111349929.HKD","SION","LU2357305700.SGD","LU0006306889.USD","LU0158827948.USD","LU1989772923.USD","BK4127","LU0971096721.USD","BK4139","BK4581","IE00BKVL7J92.USD","BK4548","BK4504","LU2023251221.USD","BK4093","LU2028103732.USD","BK4585","LU0098860793.USD","LU0158827781.USD","LU2271345857.HKD","LU0912757837.SGD","LU2089284900.SGD","LU1720051017.SGD","LU0795875169.SGD","LU0106261372.USD","LU1074936037.SGD","LU1363072403.SGD","LU1162221912.USD","BK4535","LU0267386448.USD","LU1732799900.SGD","LU0320765646.SGD","LU0795875086.SGD","LU2133065610.SGD","BK4534","BK4588","IE00BZ1G4Q59.USD","LU0314104364.USD","LU1668664300.SGD","CF","LU2089283258.USD"],"gpt_icon":0},{"id":"2512762839","title":"Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512762839","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512762839?lang=en_us&edition=fundamental","pubTime":"2025-02-18 05:43","pubTimestamp":1739828634,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks Insiders Are Buying This Year. In this article, we are going to take a look at where Sionna Therapeutics, Inc.  stands against other stocks that insiders are buying this year.Even though this is just the beginning of the year, we thought it might be interesting to see what stocks have attracted the most attention from insiders. Why?Sometimes, when executives or insiders acquire shares early in the year, it could mean that they expect strong financial results or positive company developments.On the other hand, insiders sometimes sell shares at the beginning of the year for tax reasons. For example, they can sell shares to harvest tax loss or to balance out gains/losses from the previous year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sionna-therapeutics-sion-among-stocks-214354896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CF","TSYW.SI","BK4093","NQmain","USAW.SI","BK4588",".IXIC","NVIW.SI","PSQ","QID","QLD","BK4585","TQQQ","SION","SQQQ","USJW.SI","MNQmain","BK4139"],"gpt_icon":1},{"id":"2511813505","title":"BRIEF-Orbimed Advisors Llc Reports 8.4% Stake In Sionna Therapeutics As Of Feb 10 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2511813505","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511813505?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:13","pubTimestamp":1739484801,"startTime":"0","endTime":"0","summary":"BRIEF-Orbimed Advisors Llc Reports 8.4% Stake In Sionna Therapeutics As Of Feb 10 - SEC FilingSionna Therapeutics Inc SION.O:ORBIMED ADVISORS LLC REPORTS 8.4% STAKE IN SIONNA THERAPEUTICS AS OF FEB 10 - SEC FILINGSource text: [ID:]Further company coverage: SION.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nFWN3P41ZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"gpt_icon":0},{"id":"2511850378","title":"Orbimed Advisors Llc Reports 8.4% Stake in Sionna Therapeutics as of Feb 10 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2511850378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511850378?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:12","pubTimestamp":1739484765,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nFWN3P41ZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION"],"gpt_icon":0},{"id":"2511084554","title":"Major Stock Acquisition Signals Confidence in Sionna Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2511084554","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511084554?lang=en_us&edition=fundamental","pubTime":"2025-02-13 10:07","pubTimestamp":1739412465,"startTime":"0","endTime":"0","summary":"New insider activity at Sionna Therapeutics, Inc. ( ($SION) ) has taken place on February 13, 2025. Former 10% Owner TPG GP A, LLC has made a signi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-stock-acquisition-signals-confidence-in-sionna-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-stock-acquisition-signals-confidence-in-sionna-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"gpt_icon":0},{"id":"2510884164","title":"Major Stakeholders Make Bold Moves on Sionna Therapeutics Stock!","url":"https://stock-news.laohu8.com/highlight/detail?id=2510884164","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510884164?lang=en_us&edition=fundamental","pubTime":"2025-02-11 10:05","pubTimestamp":1739239510,"startTime":"0","endTime":"0","summary":"New insider activity at Sionna Therapeutics, Inc. ( ($SION) ) has taken place on February 11, 2025. In a series of significant transactions, Direct...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-stakeholders-make-bold-moves-on-sionna-therapeutics-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-stakeholders-make-bold-moves-on-sionna-therapeutics-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"gpt_icon":0},{"id":"2510890162","title":"Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2510890162","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510890162?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:03","pubTimestamp":1739221380,"startTime":"0","endTime":"0","summary":"BOSTON, Feb.  10, 2025  (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/10/3023780/0/en/Sionna-Therapeutics-Announces-Closing-of-219-2-million-Upsized-Initial-Public-Offering-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2237443895.HKD","BK4533","IE00B19Z3581.USD","LU0106831901.USD","BK4093","LU2237443549.SGD","IE00BFXG1179.USD","LU2237443978.SGD","BK4516","IE0004091025.USD","LU2237443465.HKD","LU2237438978.USD","IE00BSNM7G36.USD","LU2237443622.USD","IE0004086264.USD","IE0034235188.USD","BK4504","LU2237443382.USD","BK4585","LU1791807156.HKD","LU1668664300.SGD","USA","BK4127","BK4552","CF","BK4550","IE0002270589.USD","SION","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2509773778","title":"Opening Day: Sionna Therapeutics, Titan America make public debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2509773778","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509773778?lang=en_us&edition=fundamental","pubTime":"2025-02-08 03:55","pubTimestamp":1738958112,"startTime":"0","endTime":"0","summary":"Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opening-day-sionna-therapeutics-titan-america-make-public-debut?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opening-day-sionna-therapeutics-titan-america-make-public-debut?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TTAM","SION"],"gpt_icon":0},{"id":"2509221227","title":"BUZZ-Sionna Therapeutics jumps nearly 40% in cracking Nasdaq debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2509221227","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509221227?lang=en_us&edition=fundamental","pubTime":"2025-02-08 02:15","pubTimestamp":1738952126,"startTime":"0","endTime":"0","summary":"BUZZ-Sionna Therapeutics jumps nearly 40% in cracking Nasdaq debutUpdates** Shares of drug developer Sionna Therapeutics SION.O jump as much as 38.9% in their Nasdaq debut; last up 38.1% at $24.86** Stock opened for trading at $25 vs $18 IPO price, giving it a market capitalization of $1.06 billion** SION sold ~10.6 million shares, 20% more than initially offered, at the top end of its marketed range of $16 to $18 apiece to raise $190.6 million** Founded in 2019 and previously known as Sling Therapeutics, SION is developing drugs to treat cystic fibrosis** SION is vying for a slice of the cystic fibrosis market that is dominated by drugmaker Vertex Pharmaceuticals VRTX.O ** Vertex booked almost $10 billion in sales in 2023 and has significantly impacted cystic fibrosis treatment** SION is evaluating its experimental drug candidates SION-719 and SION-451 in early-stage trials in Australia** Prior to the IPO, SION had raised about $330 million from investors, including RA Capital and TPG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nL4N3OY1LC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU0109394709.USD","LU1791807156.HKD","LU2237443978.SGD","LU0234570918.USD","BK4532","LU2236285917.USD","LU2362541273.HKD","VRTX","BK4516","LU0320765992.SGD","SION","LU1093756168.USD","LU2324357040.USD","IE0034235188.USD","BK4127","LU0058720904.USD","IE00BSNM7G36.USD","LU2462157665.USD","BK4585","LU0889565916.HKD","BK4139","LU0256863811.USD","IE00BFXG1179.USD","LU1668664300.SGD","SF","LU2237443549.SGD","LU2362540622.SGD","IE00B894F039.SGD","IE00B2B36J28.USD","LU0079474960.USD","LU1585245621.USD","IE0002141913.USD","IE0004086264.USD","IE00B19Z9Z06.USD","LU2456880835.USD","IE0002270589.USD","IE00B19Z3581.USD","LU2417539215.USD","IE00BZ9MQY76.HKD","IE0009355771.USD","LU1035775433.USD","LU0289739699.SGD","BK4588","BK4552","LU0061475181.USD","LU2237443465.HKD","LU1069344957.HKD","LU0417517546.SGD","LU2237438978.USD"],"gpt_icon":0},{"id":"1121625472","title":"Stock Track | Sionna Therapeutics Soars 38.89% on IPO Debut, Fueled by Strong Investor Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1121625472","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121625472?lang=en_us&edition=fundamental","pubTime":"2025-02-08 02:02","pubTimestamp":1738951353,"startTime":"0","endTime":"0","summary":"Shares of Sionna Therapeutics  surged 38.89% in its trading debut on Friday, buoyed by investor enthusiasm for the clinical-stage biopharmaceutical company's successful initial public offering .Sionna, which is developing drugs to treat cystic fibrosis, sold 10.6 million shares at $18 per share in its upsized IPO, raising $191 million. The IPO was priced at the top end of its expected range, reflecting strong investor demand for the company's shares.Based in Waltham, Massachusetts, Sionna is vyi","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Sionna Therapeutics Soars 38.89% on IPO Debut, Fueled by Strong Investor Demand","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["SION"],"gpt_icon":0},{"id":"2509533728","title":"BUZZ-Sionna Therapeutics set to open 33% above offer price after upsized $191 mln IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2509533728","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509533728?lang=en_us&edition=fundamental","pubTime":"2025-02-07 23:46","pubTimestamp":1738943213,"startTime":"0","endTime":"0","summary":"BUZZ-Sionna Therapeutics set to open 33% above offer price after upsized $191 mln IPO** Shares of drug developer Sionna Therapeutics SION.O set to open 33% above their offer price in their Nasdaq debut. ** Stock indicated to open at $24 vs $18 IPO price. ** SION sold ~10.6 mln shares, 20% more than initially offered, at the top end of its marketed range of $16 to $18 apiece to raise $190.6 mln** At the IPO price, the Waltham, Massachusetts-based firm fetched a valuation of $765.4 mln ** Founded in 2019 and previously known as Sling Therapeutics, SION is developing drugs to treat cystic fibrosis** SION is vying for a slice of the cystic fibrosis market that is dominated by drugmaker Vertex Pharmaceuticals VRTX.O ** Vertex booked almost $10 billion in sales in 2023 and has significantly impacted cystic fibrosis treatment** Prior to the IPO, SION had raised about $330 mln from investors, including RA Capital, TPG's The Rise Fund, Atlas Venture, OrbiMed and Enavate Sciences** Goldman Sachs","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nL4N3OY1FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","BK4550","LU2237443382.USD","LU0417517546.SGD","LU2237443465.HKD","LU2462157665.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","LU0061475181.USD","LU0289739699.SGD","LU0320765992.SGD","LU1069344957.HKD","IE00BFXG1179.USD","IE00BSNM7G36.USD","IE0004086264.USD","IE00B4R5TH58.HKD","LU2362541273.HKD","BK4504","IE00B894F039.SGD","IE00B19Z9P08.USD","LU1791807156.HKD","IE00B19Z3581.USD","LU1430594728.SGD","LU2456880835.USD","VRTX","BK4139","LU0079474960.USD","BK4567","LU0889565916.HKD","LU2237443895.HKD","LU0234570918.USD","LU1035775433.USD","LU1585245621.USD","LU2237443978.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4552","LU2237443622.USD","SION","LU1668664300.SGD","LU2237438978.USD","LU2362540622.SGD","IE0004091025.USD","LU0109394709.USD","BK4585","BK4516","BK4533","SF","IE0002270589.USD","IE00BJT1NW94.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":45,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SION\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"SION","fiscalQuarterEnding":"2025/03","expectedEps":-0.45,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.62}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SION\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SION\",market:\"US\",delay:true,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SION\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"SION","date":"2025-06-06","current":-10.656886,"percent":0.325301,"low":-18.418073,"twenty":-12.42503,"median":-9.227154,"eighty":-8.395596,"high":-5.47907,"avg":-10.13363,"sd":2.665702,"marketCap":706796635},"quantilePoints":[{"date":"2025-02-07","current":-13.261013,"twenty":-12.252025,"median":-10.738543,"eighty":-9.22506,"marketCap":765372600},{"date":"2025-02-14","current":-14.940741,"twenty":-16.115077,"median":-14.940741,"eighty":-13.535074,"marketCap":862319796},{"date":"2025-02-21","current":-15.365065,"twenty":-15.365065,"median":-14.763927,"eighty":-14.631317,"marketCap":886810118},{"date":"2025-02-28","current":-11.280197,"twenty":-15.101402,"median":-14.760244,"eighty":-13.045594,"marketCap":651047865},{"date":"2025-03-07","current":-11.960372,"twenty":-15.059369,"median":-14.631317,"eighty":-11.310767,"marketCap":690304817},{"date":"2025-03-14","current":-13.068521,"twenty":-15.036515,"median":-13.072343,"eighty":-11.387191,"marketCap":754262771},{"date":"2025-03-21","current":-10.607665,"twenty":-14.940741,"median":-12.594692,"eighty":-11.280197,"marketCap":612232003},{"date":"2025-03-28","current":-8.569094,"twenty":-14.763927,"median":-12.189644,"eighty":-10.607665,"marketCap":528610240},{"date":"2025-04-04","current":-8.304439,"twenty":-14.75656,"median":-11.44833,"eighty":-8.654927,"marketCap":512284214},{"date":"2025-04-11","current":-5.47907,"twenty":-14.719724,"median":-11.345158,"eighty":-8.304439,"marketCap":337992858},{"date":"2025-04-17","current":-7.152833,"twenty":-14.648998,"median":-11.146455,"eighty":-7.438946,"marketCap":441243940},{"date":"2025-04-25","current":-9.012569,"twenty":-13.535074,"median":-10.607665,"eighty":-7.830921,"marketCap":555967364},{"date":"2025-05-02","current":-9.227154,"twenty":-13.113134,"median":-10.157913,"eighty":-8.049798,"marketCap":569204682},{"date":"2025-05-09","current":-8.991111,"twenty":-13.07005,"median":-9.363058,"eighty":-8.189398,"marketCap":554643632},{"date":"2025-05-16","current":-8.935031,"twenty":-13.050179,"median":-9.227154,"eighty":-8.189398,"marketCap":592598052},{"date":"2025-05-23","current":-8.649163,"twenty":-12.684872,"median":-9.227154,"eighty":-8.258154,"marketCap":573638442},{"date":"2025-05-30","current":-9.380453,"twenty":-12.498397,"median":-9.212848,"eighty":-8.290133,"marketCap":622139770},{"date":"2025-06-06","current":-10.656886,"twenty":-12.42503,"median":-9.227154,"eighty":-8.395596,"marketCap":706796635}],"updateTime":1749473717905}}}